secwatch.observer — SEC 8-K summary
======================================

Issuer:     Vaxcyte, Inc. (PCVX)
CIK:        0001649094
Form:       8-K
Filed at:   2023-11-28T23:59:59+00:00
Accession:  0001193125-23-283769
Event type: leadership
Sentiment:  neutral
Materiality: 0.30
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Vaxcyte appoints Jacks Lee to Board of Directors, effective Nov 27, 2023
------------------------------------------------------------------------

- Jacks Lee appointed as Class II director, term expires at 2025 annual meeting.
- Lee appointed to Audit Committee; Board determined independent under Nasdaq rules.
- Initial grant of 30,000 stock options, vesting 1/3 at one year and monthly over 36 months.
- Annual grants: option for 15,000 shares and 2,500 RSUs, with accelerated vesting on change of control.
- Annual cash retainers: $40,000 for Board service, plus $10,000 for Audit Committee.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1649094/000119312523283769/0001193125-23-283769-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1649094/000119312523283769/d604212d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-283769

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer